Your browser is no longer supported. Please, upgrade your browser.
Settings
GWPH GW Pharmaceuticals plc daily Stock Chart
GWPH [NASD]
GW Pharmaceuticals plc
Index- P/E- EPS (ttm)-9.66 Insider Own0.68% Shs Outstand27.21M Perf Week12.37%
Market Cap3.79B Forward P/E89.27 EPS next Y1.56 Insider Trans-10.89% Shs Float1.48M Perf Month26.57%
Income-255.20M PEG- EPS next Q-2.21 Inst Own80.30% Short Float- Perf Quarter-4.16%
Sales16.80M P/S225.55 EPS this Y-101.80% Inst Trans0.91% Short Ratio- Perf Half Y-4.76%
Book/sh14.17 P/B9.83 EPS next Y123.60% ROA-46.10% Target Price173.17 Perf Year5.17%
Cash/sh12.75 P/C10.93 EPS next 5Y- ROE-52.70% 52W Range90.14 - 179.65 Perf YTD42.99%
Dividend- P/FCF- EPS past 5Y- ROI-67.80% 52W High-22.48% Beta2.70
Dividend %- Quick Ratio11.20 Sales past 5Y-14.10% Gross Margin66.90% 52W Low54.49% ATR6.42
Employees769 Current Ratio11.30 Sales Q/Q50.00% Oper. Margin- RSI (14)73.53 Volatility4.72% 6.15%
OptionableYes Debt/Eq0.03 EPS Q/Q-63.70% Profit Margin- Rel Volume1.21 Prev Close137.29
ShortableYes LT Debt/Eq0.03 EarningsFeb 26 AMC Payout- Avg Volume509.45K Price139.26
Recom2.10 SMA2023.85% SMA5015.03% SMA2000.63% Volume617,149 Change1.43%
Jan-02-19Initiated JP Morgan Overweight $134
Nov-05-18Resumed Piper Jaffray Overweight
Sep-28-18Reiterated BofA/Merrill Buy $181 → $197
Sep-07-18Resumed Morgan Stanley Overweight
Aug-15-18Initiated Stifel Buy $181
Aug-08-18Reiterated Cantor Fitzgerald Overweight $235 → $211
Apr-19-18Reiterated Cantor Fitzgerald Overweight $192 → $205
Feb-06-18Reiterated Cantor Fitzgerald Buy $208 → $192
Dec-14-17Upgrade Goldman Neutral → Buy
Oct-06-17Resumed Goldman Neutral
Aug-17-17Initiated Evercore ISI Outperform $154
Aug-08-17Downgrade Maxim Group Buy → Hold
Apr-21-17Initiated Maxim Group Buy $135
Dec-05-16Reiterated Cantor Fitzgerald Buy $182 → $208
Oct-07-16Initiated Goldman Buy
Oct-04-16Resumed Leerink Partners Outperform $162
Sep-26-16Reiterated Cantor Fitzgerald Buy $165 → $182
Aug-26-16Upgrade Numis Sell → Hold
Aug-09-16Reiterated Cantor Fitzgerald Buy $181 → $165
Jun-03-16Initiated Cantor Fitzgerald Buy $181
Jan-22-19 02:05PM  4 Marijuana Stocks Getting A Boost From Today's Headlines ACCESSWIRE
08:35AM  4 Marijuana Stocks That Look Profitable in 2019 Zacks
Jan-21-19 09:56AM  Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week Benzinga
Jan-18-19 07:43AM  Jim Cramer Advises His Viewers On Brink's, Medtronic And More Benzinga
Jan-17-19 06:48PM  Cramer's lightning round: 'I'm not endorsing' Fiat Chrysler's stock anymore CNBC
03:25PM  4 Marijuana Stocks Looking To Have A Banner Month ACCESSWIRE
09:00AM  Mugglehead reveals a number of stocks set to take advantage of hemp GlobeNewswire
Jan-15-19 02:15PM  4 Marijuana Stocks Leading Tuesday's Bull Charge ACCESSWIRE
Jan-12-19 09:06AM  The Must-See Marijuana Commentary From the U.S. Surgeon General Motley Fool
Jan-11-19 10:00AM  These 4 Marijuana Stocks Are Hitting Their Stride ACCESSWIRE
Jan-10-19 10:13AM  Zacks Market Edge Highlights: Tilray, Constellation Brands, Altria and GW Pharmaceuticals Zacks
08:10AM  4 Marijuana Stocks Setting The Stage On Thursday (1/10/19) ACCESSWIRE
Jan-09-19 07:33PM  [$$] Health-Care CEOs Outline Strategies at J.P. Morgan Conference The Wall Street Journal
05:49PM  Edited Transcript of GWPH.O earnings conference call or presentation 27-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
12:30PM  Watch These 4 Marijuana Stocks On Wednesday (1/9/19) ACCESSWIRE
12:04PM  Pot Stocks in 2019: A Year of Transition Zacks
08:15AM  7 Reasons GW Pharmaceuticals' Epidiolex Will Be a Big Winner Motley Fool
04:20AM  Future of GW Pharmaceuticals Stock Hinges on Recent Floors and Ceilings InvestorPlace
Jan-07-19 08:40AM  Watch These 4 Marijuana Stocks On Monday (1/7/19) ACCESSWIRE +5.31%
Jan-04-19 05:11PM  Which Biopharma Stocks Are Looking To Score Big In Cannabis Medicine? Investor's Business Daily +9.22%
04:00PM  Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week Benzinga
11:40AM  Watch These 4 Marijuana Stocks On Friday (1/4/19) ACCESSWIRE
Jan-03-19 12:03PM  4 Marijuana Stocks Looking To Have A Strong New Year ACCESSWIRE
07:09AM  JPMorgan Thinks This Pot Stock Is a "Clear Leader" Investopedia
07:00AM  Today's Research Reports on Trending Tickers: GW Pharmaceuticals and Perrigo Company ACCESSWIRE
Jan-02-19 03:48PM  Cannabis, Migraines, Gene-Silencing: FDA Approvals Hit High Note In 2018 Investor's Business Daily
12:40PM  GW Pharma's stock jumps after J.P. Morgan initiates the cannabinoid company with a bullish rating MarketWatch
08:21AM  The Fastest-Growing Marijuana Stocks in 2019 Motley Fool
Dec-31-18 11:00AM  Cannabis Firms Set to Explode ACCESSWIRE
07:00AM  GW Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference GlobeNewswire
Dec-30-18 10:21AM  4 Big-Name Pot Stocks That'll Lose Money in 2019 Motley Fool
Dec-28-18 04:54PM  Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week Benzinga
Dec-24-18 05:50PM  GW Pharmaceuticals PLC (GWPH) Gains As Market Dips: What You Should Know Zacks
Dec-23-18 10:07PM  Hemp is now legal in the U.S., so what does that mean for pot companies? MarketWatch
09:06AM  15 Ways Marijuana Has Made History in 2018 Motley Fool
09:01AM  7 Bold and Audacious Predictions for Marijuana Stocks in 2019 Motley Fool
Dec-21-18 04:53PM  Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week Benzinga -7.44%
03:25PM  Top Marijuana Stocks to Watch Investopedia
08:06AM  More Than 1.9 Million Californians May Own Pot Stocks Without Realizing It Motley Fool
Dec-20-18 04:40PM  Hemp Is Now Legal Thanks to the Farm Bill. Here Comes the FDA Bloomberg -5.38%
Dec-19-18 12:20PM  Cara Therapeutics Stock Could Outperform in 2019 InvestorPlace
11:00AM  Kali-Extracts, Inc. Releases Preclinical Research Study Results on Therapy for Respiratory Disease Driving $11 Billion Treatment Market PR Newswire
06:50AM  Today's Research Reports on Trending Tickers: GW Pharmaceuticals and Aphria ACCESSWIRE
Dec-18-18 09:41AM  This Could Be the Biggest Marijuana News in 2018 Motley Fool -5.32%
08:55AM  Biotechs Were Innovators In 2018: Here Are The Top New Molecules That Were Approved Benzinga
Dec-17-18 10:37PM  Hedge Funds Arent Crazy About GW Pharmaceuticals plc (GWPH) Anymore Insider Monkey
05:25PM  Ask Our Experts 12/16/2018 Benzinga
12:40PM  Medical Marijuana Stocks Take Center Stage Amid Farm Bill Excitement ACCESSWIRE
Dec-16-18 09:06AM  Hemp! Hemp! Hooray! Congress Passes the Farm Bill Motley Fool
Dec-14-18 06:59PM  Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week Benzinga
05:45PM  GW Pharmaceuticals PLC (GWPH) Stock Moves -1.1%: What You Should Know Zacks
Dec-13-18 08:40AM  4 Marijuana Stocks To Watch On Thursday ACCESSWIRE
Dec-12-18 11:17AM  Why Marijuana Stock GW Pharmaceuticals Dropped 10.5% in November Motley Fool
09:30AM  Cannabis Winners in 2018 Poised for a Bigger 2019 ACCESSWIRE
08:30AM  Electricity Usage By Cannabis Growers Ballooning ACCESSWIRE
Dec-11-18 09:45AM  Marijuana Stocks Gain Attention As Cannabis Industry Jobs Grow ACCESSWIRE
Dec-09-18 09:06AM  2 Must-Read Quotes on Marijuana From FDA Head Scott Gottlieb Motley Fool
09:00AM  Better Marijuana Stock: Cronos Group vs. GW Pharmaceuticals Motley Fool
Dec-07-18 12:30PM  What the Future Holds for Canopy Growth Stock InvestorPlace
Dec-05-18 08:21AM  These 17 Pot Stocks Were Throttled in November Motley Fool
Dec-04-18 05:45PM  GW Pharmaceuticals PLC (GWPH) Gains As Market Dips: What You Should Know Zacks
12:20PM  Bank Of America Bullish On GW Pharma, Expects Growth In Epidiolex Sales Benzinga
09:00AM  Marijuana Stocks Get Boost On Deal News ACCESSWIRE
Dec-03-18 03:01PM  Cantor Fitzgerald Lowers GW Pharmaceuticals Price Target Benzinga
12:16PM  How dangerous are marijuana stocks? Even a company with notable achievements has plunged MarketWatch
10:45AM  The Marijuana Stocks Making Waves This Week ACCESSWIRE
Dec-01-18 09:06AM  The 12 Largest Marijuana Stocks Motley Fool
08:21AM  You'll Never Guess Which Asian Country Just Legalized Medical Marijuana Motley Fool
Nov-30-18 10:23AM  Serious Questions Surround CV Sciences Stock InvestorPlace
Nov-29-18 10:27AM  Cannabis Cash From High-Less Hemp Beckons to Ailing U.S. Farmers Bloomberg
07:30AM  Investor Expectations to Drive Momentum within ANSYS, Nordic American Tankers, Woodward, GW Pharmaceuticals, CareTrust REIT, and TOCAGEN INC Discovering Underlying Factors of Influence GlobeNewswire
Nov-28-18 03:11PM  Cantor Fitzgerald Bullish On GW Pharmaceuticals, Sees 75% Upside Potential Benzinga
08:21AM  3 Marijuana Stocks to Avoid Like the Plague in December Motley Fool
07:46AM  The Daily Biotech Pulse: IntelliPharmaCeutics Generic Antidepressant Gets FDA Nod, GW Pharma Earnings Benzinga
Nov-27-18 11:32PM  GW Pharmaceuticals Plc (GWPH) Q4 2018 Earnings Conference Call Transcript Motley Fool
05:48PM  GW Pharmaceuticals (GWPH) Stock Is Sliding on Q4 Revenue Miss InvestorPlace
05:05PM  GW Pharma Slides After Cannabis-Based Biotech Lags Sales Views Investor's Business Daily
04:47PM  GW Pharma Beats Q4 EPS Estimates, Misses On Revenue Benzinga
04:42PM  GW Pharmaceuticals stock ticks down after revenue miss MarketWatch
04:00PM  GW Pharmaceuticals plc Reports Fiscal Fourth Quarter and Year-End 2018 Financial Results and Operational Progress GlobeNewswire
11:15AM  Cannabis-Based Drug (Still) Helps Epilepsy, but How Safe Is It? Motley Fool
09:44AM  Company News For Nov 27, 2018 Zacks
07:26AM  GW Pharmaceuticals Q4 Earnings Preview Benzinga
06:30AM  TLRY and NMTC: Two Takes On Treating Brain Disorders That Could Be Worth Billions ACCESSWIRE
Nov-26-18 12:46PM  Marijuana Stocks: GW Phamaceuticals Stock Surges on Late-Stage Study Success InvestorPlace
10:40AM  Healthcare Stocks Rally Has Investors Looking At These 4 Companies ACCESSWIRE
09:53AM  Additional Late-Stage Study Confirms Efficacy, Safety Of GW Pharma's Epidiolex Benzinga
07:29AM  UPDATE: GW Pharma shares up 2.4% premarket on news of positive trial for cannabis-based drug MarketWatch
07:00AM  Today's Research Reports on Trending Tickers: GW Pharmaceuticals and Sage Therapeutics ACCESSWIRE
07:00AM  GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for EPIDIOLEX® (cannabidiol) oral solution CV in Patients with Dravet Syndrome GlobeNewswire
02:00AM  FSD Pharma Appoints Top GW Pharmaceuticals Executive, Rupert Haynes, as Chief Executive Officer CNW Group
Nov-24-18 09:06AM  Forget THC! Cannabidiol (CBD) Is the Marijuana Industry's Moneymaker Motley Fool
07:33AM  Better Buy: GW Pharmaceuticals vs. Corbus Pharmaceuticals Motley Fool
Nov-23-18 04:54PM  Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week Benzinga
10:11AM  What's in Store for GW Pharma (GWPH) This Earnings Season? Zacks
Nov-19-18 04:05PM  GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on EPIDIOLEX® (cannabidiol) Oral Solution at the American Epilepsy Society Annual Meeting GlobeNewswire -5.22%
09:45AM  4 Marijuana Stocks Expanding Across North America ACCESSWIRE
Nov-16-18 02:44PM  4 Lit Marijuana Stocks to Buy Kiplinger
Nov-15-18 03:00PM  What Is CBD And How Can Investors Take Advantage Of It? Benzinga
Nov-14-18 12:43PM  4 Reasons Why Leerink Is Bullish On GW Pharma Benzinga
GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. Its lead product is Epidiolex, an oral medicine for the treatment of refractory childhood epilepsies, as well as for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, and infantile spasms. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates for the treatment of glioblastoma, neonatal hypoxic-ischemic encephalopathy, and schizophrenia. Further, the company has license and development agreements with Almirall S.A.; Bayer HealthCare AG; Ipsen Biopharm Ltd; and Neopharm Group. It primarily operates in Europe, the United Kingdom, the United States, Canada, and Asia. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gover Justin D.Chief Executive OfficerJan 02Sale8.3322,620188,407393,065Jan 04 04:15 PM
Gover Justin D.Chief Executive OfficerDec 20Option Exercise0.0045,24059415,685Dec 26 04:15 PM
George Adam D.SecretaryNov 21Option Exercise0.0010,0001310,000Nov 23 04:30 PM